CDNA

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 84.69 M86.68 M100.06 M108.39 M117.7 M 412.82 M Gross profit 84.69 M86.68 M100.06 M108.39 M117.7 M 412.82 M Operating expenses 98.06 M97.8 M100.3 M114.43 M116.5 M 429.03 M Selling/general/admin expenses 45.76 M51.96 M52.88 M59.61 M60.86 M 225.31 M Research & development 18.52 M16.83 M16.77 M19.31 M21.42 M 74.32 M Operating income -13.37 M-11.12 M-246 K-6.04 M1.2 M -16.21 M Non-Operating Income, Total 3.08 M2.44 M1.91 M2.28 M1.58 M 8.2 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 2.78 M2.36 M2.01 M2.01 M1.91 M 8.3 M Unusual income/expense 295 K72 K-107 K264 K-330 K -101 K Pretax income -10.29 M-8.69 M1.66 M-3.76 M2.78 M -8.01 M Equity in earnings ————— — Taxes 58 K-117 K-15 K345 K-32.01 K 180.99 K Non-controlling/minority interest ————— — After tax other income/expense 7 0000-55 K—-15 K — Net income before discontinued operations -10.35 M-8.57 M1.68 M-4.11 M2.81 M -8.19 M Discontinued operations ————— — Net income -10.35 M-8.57 M1.68 M-4.11 M2.81 M -8.19 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -10.35 M-8.57 M1.68 M-4.11 M2.81 M -8.19 M Basic earnings per share (Basic EPS) -0.19-0.160.03-0.080.05 -0.16 Diluted earnings per share (Diluted EPS) -0.19-0.160.03-0.080.05 -0.16 Average basic shares outstanding 55.26 M54.3 M52.51 M53.29 M51.15 M — Diluted shares outstanding 55.26 M54.3 M53.74 M53.29 M53.13 M — EBITDA -9.77 M-7.4 M3.57 M-2.16 M5.1 M -892 K EBIT -13.37 M-11.12 M-246 K-6.04 M1.2 M -16.21 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.6 M3.72 M3.81 M3.88 M3.9 M 15.32 M